StockData
HCW Biologics Inc. logo

HCW Biologics Inc. (HCWB) stock

HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)

Close on Nov 18, 2026Market cap $1.40MP/E –Yield –

HCW Biologics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

HCW Biologics's price to book ratio was 0.1× on Nov 11, 2026, against 4.5× a year earlier. Over the last 4 years it ranged from 0.1× to 4.7×, with a median of 1.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.1×−2.4
2024Jul 31, 20242.5×+0.7
2023Dec 29, 20231.8×+0.2
2022Dec 30, 20221.6×+1.1
2021Dec 31, 20210.5×–

More HCW Biologics figures

See a number that looks wrong?